PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone

NCT02265406 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

354

Enrollment

OTHER

Sponsor class

Conditions

Early Ventilation Acquired Pneumonia in Brain Injured Patients

Interventions

DRUG: Anti-Infective Agents
DRUG: Placebo

Sponsor

Poitiers University Hospital